Nutra Pharma Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 11/17/2016
Contact Info
  • 12502 West Atlantic Blvd
  • Coral Springs, FL 33071

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001119643
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: CA, USA
Year of Inc. 2000
Employees 5 a/o Sep 30, 2015
Company Officers/Contacts
Rik Deitsch President, CEO, CFO
Dale Vanderputten Chief Scientific Officer
Nina Goldstein IR
Company Directors
Rik Deitsch Chairman
Stewart Lonky
Garry Pottruck
Harold Rumph
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States
Securities Counsel
Dickinson Wright PLLC OTCQX Sponsor
International Square
1875 Eye Street N.W.
Suite 1200
DC, 20006
United States
Investor Relations Firm

Not Available
Company History
  • Note=12-31-04 company is in the development stage
  • until 11-01
NPHC Security Details
Share Structure
Market Value1 $1,011,351 a/o Mar 23, 2017
Authorized Shares 2,000,000,000 a/o Nov 16, 2016
Outstanding Shares 255,391,579 a/o Nov 21, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 118,296,557 a/o Nov 16, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Standard Registrar and Transfer Co., Inc.
Shareholders of Record Not Available
Short Selling Data
Short Interest 36,134 (30,522.029%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security